The area under the ROC curve of CBX5 was only 0.5299, and CBX5 mRNA expression was not significantly correlated with the prognosis of BLCA patients, which indicated that CBX5 was not suitable as a molecular marker of BLCA. Here, CBX5 is linked to bladder transitional cell carcinoma.